Skip to main content
Revive Therapeutics Ltd. logo

Revive Therapeutics Ltd. — Investor Relations & Filings

Ticker · RVV ISIN · CA7615161030 LEI · 967600MT7D67TXWXB884 CSE Manufacturing
Open in API
Filings indexed 222 across all filing types
Latest filing 2025-12-15 Regulatory Filings
Country CA Canada
Listing CSE RVV

About Revive Therapeutics Ltd.

https://revivethera.com/

Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders. The company's pipeline includes the investigation of Bucillamine for public health medical emergencies and rare inflammatory disorders, alongside the advancement of Psilocybin-based therapeutics. Revive prioritizes leveraging FDA regulatory incentives, such as Orphan Drug and Fast Track designations, to accelerate its drug development programs.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release issued by Revive Therapeutics providing an update on a research study regarding Bucillamine. It does not fit into specific categories like financial reports, dividend announcements, or board changes. As it is a general corporate announcement regarding operational progress, it falls under the 'Regulatory Filings' (RNS) category as the fallback for miscellaneous corporate news.
2025-12-15 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings Classification · 82% confidence The document is a Form 52-109FV1 “Certification of Annual Filings” under Canadian NI 52-109. It is a regulatory certificate by the CEO confirming the review and fair presentation of annual financial statements and MD&A, not the annual report itself. It is not an earnings release, management discussion, proxy or similar. This is a standalone compliance filing required by securities legislation and thus falls under the fallback Regulatory Filings category.
2025-10-28 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings Classification · 82% confidence The document is Form 52-109FV1, a certification under Canadian NI 52-109 for venture issuers signing off on annual filings. It is not the annual report itself, nor an earnings release or MD&A. It is a required regulatory certificate/filing. None of the specific categories (e.g., 10-K, IR, ER) match this certification form, so it falls under the general Regulatory Filings category (RNS).
2025-10-28 English
Annual MD&A - English.pdf
Management Reports Classification · 95% confidence The document is a detailed Management’s Discussion and Analysis (MD&A) covering the results of operations, financial condition, corporate developments, and outlook for the year ended June 30, 2025. It is not merely an announcement of a report but the full MD&A itself, which aligns directly with the “Management Reports” category (Code: MDA).
2025-10-28 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 98% confidence The document is a Form 13-501F1 submission to the Alberta Securities Commission including management certification and participation fee details. It is a regulatory form and does not fit other specific categories like financial reports, earnings releases, or management changes. As it is a miscellaneous regulatory filing with fee schedules, it falls into the fallback category Regulatory Filings (RNS).
2025-10-28 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 90% confidence The document is a Form 13-502F1 fee submission to the Ontario Securities Commission, detailing market values, average values, and participation fees. It is a mandatory regulatory filing under OSC Rule 13-502 Fees, not an investor-facing report (like a 10-K or IR) nor an announcement of an upcoming report. This does not match any specific category (e.g., earnings release, proxy materials, capital changes) and fits as a general regulatory submission. Therefore, it is classified as a Regulatory Filing (RNS).
2025-10-28 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.